Trial intelligence / Profile preview

Enoxaparin vs unfractionated heparin in ST-elevation myocardial infarction

IRCT138711271695N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2006
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of enoxaparin, heparin in myocardial infarction (MI), sponsored by Tehran University of Medical Sciences. Started Jun 2006; status: completed.

02

Drugs

enoxaparinheparin
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on IRCT138711271695N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138711271695N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call